Clinical journal of the American Society of Nephrology : CJASN
-
Clin J Am Soc Nephrol · May 2010
Randomized Controlled TrialRandomized trial of model predictive control for improved anemia management.
Variable hemoglobin (Hb) response to erythropoiesis stimulating agents may result in adverse outcomes. The utility of model predictive control for drug dosing was previously demonstrated. ⋯ Model predictive control of erythropoietin administration improves anemia management.